Document Detail


The prognostic influence of resection margin clearance following pancreaticoduodenectomy for pancreatic ductal adenocarcinoma.
MedLine Citation:
PMID:  23297028     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
INTRODUCTION: The poor overall survival associated with pancreatic ductal adenocarcinoma (PDAC) despite complete resection suggests that occult metastatic disease is present in most at the time of surgery. Resection margin involvement (R1) following resection is an established poor prognostic factor. However, the definition of an R1 resection varies and the impact of margin clearance on outcome has not been examined in detail.
METHODS: In a cohort of 217 consecutive patients who underwent pancreaticoduodenectomy for PDAC with curative intent at a single institution between 1996 and 2011, the prognostic significance of the proximity of margin clearance was investigated. Microscopic margin clearance was stratified by 0.5 mm increments from tumor present at the margin to >2.0 mm. Groups were dichotomized into clear and involved groups according to the different R1 definitions. Multivariate survival analysis was used to establish independent prognostic factors.
RESULTS: For the 38 patients (17.5 %) where the tumor was >1.5 mm from the closest involved margin, there was a significantly prolonged overall median survival (63.1 months; 95 % confidence interval, 32.5-93.8) compared to R1 resections (16.9 months; 95 % confidence interval, 14.5-19.4; P < 0.0001, log-rank test). This cutoff represented the optimum distance for predicting long-term survival. As margin clearance increased, R1 status became a more powerful independent predictor of outcome; however, margin clearance did not relate to site of tumor recurrence.
CONCLUSION: These data demonstrate that margin clearance by at least 1.5 mm identifies a subgroup of patients which may potentially achieve long-term survival. This study further confirms the need to achieve standardization across pancreatic specimen reporting. Stratification of patients into future clinical trials based upon the degree of margin clearance may identify those patients likely to benefit from adjuvant therapy.
Authors:
Nigel B Jamieson; Nigel I J Chan; Alan K Foulis; Euan J Dickson; Colin J McKay; C Ross Carter
Related Documents :
16030028 - Primary chemotherapy with gemcitabine as prolonged infusion, non-pegylated liposomal do...
3731648 - Splenectomy for splenic metastasis from carcinoma of colon.
Publication Detail:
Type:  Journal Article     Date:  2013-01-08
Journal Detail:
Title:  Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract     Volume:  17     ISSN:  1873-4626     ISO Abbreviation:  J. Gastrointest. Surg.     Publication Date:  2013 Mar 
Date Detail:
Created Date:  2013-02-11     Completed Date:  2013-09-12     Revised Date:  2014-07-22    
Medline Journal Info:
Nlm Unique ID:  9706084     Medline TA:  J Gastrointest Surg     Country:  United States    
Other Details:
Languages:  eng     Pagination:  511-21     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adenocarcinoma / secondary*,  surgery*
Adult
Aged
Aged, 80 and over
Female
Humans
Kaplan-Meier Estimate
Lymphatic Metastasis
Male
Middle Aged
Multivariate Analysis
Neoplasm Grading
Neoplasm Staging
Neoplasm, Residual
Pancreatic Ducts
Pancreatic Neoplasms / pathology*,  surgery*
Pancreaticoduodenectomy*
Prognosis
Proportional Hazards Models
Retrospective Studies
Survival Rate
Time Factors
Grant Support
ID/Acronym/Agency:
CAF/06/24//Chief Scientist Office

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Proceedings of the 46th Annual Pancreas Club Meeting.
Next Document:  The Role of Cytology in the Preoperative Assessment and Management of Patients with Pancreaticobilia...